Business, energy, technology, markets and global industry news from Business News Today

FDA regulatory strategy

Pharma & Biotech

How Kenox Pharmaceuticals is targeting the OINDP CDMO gap with integrated clinical manufacturing

Kenox Pharmaceuticals announces clinical manufacturing readiness for inhaled and nasal drug products. What this means for OINDP development timelines and IVBE strategy.

Read More
Pharma & Biotech

What Cloudbreak Pharma’s Phase 2 FDA meeting reveals about late-stage risk in ophthalmic drug development

Find out how Cloudbreak Pharma’s Phase 2 FDA meeting reshapes late-stage risk for CBT-004 and what it signals for ophthalmic drug development.

Read More